234 related articles for article (PubMed ID: 26484916)
21. Early glycogen synthase kinase-3β and protein phosphatase 2A independent tau dephosphorylation during global brain ischaemia and reperfusion following cardiac arrest and the role of the adenosine monophosphate kinase pathway.
Majd S; Power JH; Koblar SA; Grantham HJ
Eur J Neurosci; 2016 Aug; 44(3):1987-97. PubMed ID: 27177932
[TBL] [Abstract][Full Text] [Related]
22. Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease.
Park HJ; Lee KW; Oh S; Yan R; Zhang J; Beach TG; Adler CH; Voronkov M; Braithwaite SP; Stock JB; Mouradian MM
J Neuropathol Exp Neurol; 2018 Feb; 77(2):139-148. PubMed ID: 29281045
[TBL] [Abstract][Full Text] [Related]
23. GSK-3beta acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis.
Lin CF; Chen CL; Chiang CW; Jan MS; Huang WC; Lin YS
J Cell Sci; 2007 Aug; 120(Pt 16):2935-43. PubMed ID: 17666435
[TBL] [Abstract][Full Text] [Related]
24. Interactions between glycogen synthase kinase 3beta, protein kinase B, and protein phosphatase 2A in tau phosphorylation in mouse N2a neuroblastoma cells.
Zhou XW; Winblad B; Guan Z; Pei JJ
J Alzheimers Dis; 2009; 17(4):929-37. PubMed ID: 19542610
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
[TBL] [Abstract][Full Text] [Related]
26. B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A.
Nicolia V; Fuso A; Cavallaro RA; Di Luzio A; Scarpa S
J Alzheimers Dis; 2010; 19(3):895-907. PubMed ID: 20157245
[TBL] [Abstract][Full Text] [Related]
27. Glycogen synthase kinase-3β suppresses the expression of protein phosphatase methylesterase-1 through β-catenin.
Jin N; Shi R; Jiang Y; Chu D; Gong CX; Iqbal K; Liu F
Aging (Albany NY); 2019 Nov; 11(21):9672-9688. PubMed ID: 31714894
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-induced tau phosphorylation and memory deficit in rats.
Zhang CE; Yang X; Li L; Sui X; Tian Q; Wei W; Wang J; Liu G
Neurodegener Dis; 2014; 14(3):107-16. PubMed ID: 24993525
[TBL] [Abstract][Full Text] [Related]
29. Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3β.
Kawakami F; Shimada N; Ohta E; Kagiya G; Kawashima R; Maekawa T; Maruyama H; Ichikawa T
FEBS J; 2014 Jan; 281(1):3-13. PubMed ID: 24165324
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
[TBL] [Abstract][Full Text] [Related]
31. Okadaic acid-induced Tau phosphorylation in rat brain: role of NMDA receptor.
Kamat PK; Rai S; Swarnkar S; Shukla R; Ali S; Najmi AK; Nath C
Neuroscience; 2013 May; 238():97-113. PubMed ID: 23415789
[TBL] [Abstract][Full Text] [Related]
32. Perinatal exposure to lead (Pb) promotes Tau phosphorylation in the rat brain in a GSK-3β and CDK5 dependent manner: Relevance to neurological disorders.
Gąssowska M; Baranowska-Bosiacka I; Moczydłowska J; Tarnowski M; Pilutin A; Gutowska I; Strużyńska L; Chlubek D; Adamczyk A
Toxicology; 2016 Mar; 347-349():17-28. PubMed ID: 27012722
[TBL] [Abstract][Full Text] [Related]
33. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
[TBL] [Abstract][Full Text] [Related]
34. Effects of Single-Dose and Long-Term Ketamine Administration on Tau Phosphorylation-Related Enzymes GSK-3β, CDK5, PP2A, and PP2B in the Mouse Hippocampus.
Li Y; Wen G; Ding R; Ren X; Jing C; Liu L; Yao J; Zhang G; Lu Y; Li B; Wu X
J Mol Neurosci; 2020 Dec; 70(12):2068-2076. PubMed ID: 32705526
[TBL] [Abstract][Full Text] [Related]
35. Calcineurin dephosphorylates glycogen synthase kinase-3 beta at serine-9 in neuroblast-derived cells.
Kim Y; Lee YI; Seo M; Kim SY; Lee JE; Youn HD; Kim YS; Juhnn YS
J Neurochem; 2009 Oct; 111(2):344-54. PubMed ID: 19659461
[TBL] [Abstract][Full Text] [Related]
36. Parkinson's disease-associated DJ-1 mutations increase abnormal phosphorylation of tau protein through Akt/GSK-3β pathways.
Wang Y; Liu W; He X; Zhou F
J Mol Neurosci; 2013 Nov; 51(3):911-8. PubMed ID: 23979838
[TBL] [Abstract][Full Text] [Related]
37. Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A.
Zhou XW; Gustafsson JA; Tanila H; Bjorkdahl C; Liu R; Winblad B; Pei JJ
Neurobiol Dis; 2008 Sep; 31(3):386-94. PubMed ID: 18586097
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation.
Selenica ML; Jensen HS; Larsen AK; Pedersen ML; Helboe L; Leist M; Lotharius J
Br J Pharmacol; 2007 Nov; 152(6):959-79. PubMed ID: 17906685
[TBL] [Abstract][Full Text] [Related]
39. Atorvastatin Alleviates Experimental Diabetic Cardiomyopathy by Regulating the GSK-3β-PP2Ac-NF-κB Signaling Axis.
Ren XM; Zuo GF; Wu W; Luo J; Ye P; Chen SL; Hu ZY
PLoS One; 2016; 11(11):e0166740. PubMed ID: 27851811
[TBL] [Abstract][Full Text] [Related]
40. GSK-3β and ERK1/2 incongruously act in tau hyperphosphorylation in SPS-induced PTSD rats.
Wei Z; Mahaman YAR; Zhu F; Wu M; Xia Y; Zeng K; Yang Y; Liu R; Wang JZ; Shu X; Wang X
Aging (Albany NY); 2019 Sep; 11(18):7978-7995. PubMed ID: 31548435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
